<html>
<head>PUBMED IDs for CEPO</head>
<body bgcolor='#C5F0F2'><h1>CEPO</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9811702/'>Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.</a> November 13  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/19085770/'>[Erythropoietin - state of science].</a> April 25  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19085698/'>The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.</a> July 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20163877/'>Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells.</a> April 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21596035/'>Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.</a> August 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21596034/'>Significance of DC-LAMP and DC-SIGN expression in psoriasis vulgaris lesions.</a> September 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23160767/'>Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23160753/'>Inflammatory bowel disease: an impaired barrier disease.</a> June 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25790933/'>Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.</a> January 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25790929/'>Public perceptions of disease severity but not actionability correlate with interest in receiving genomic results: nonalignment with current trends in practice.</a> September 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27055825/'>ICEPO: the ion channel electrophysiology ontology.</a> October 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27055815/'>Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.</a> November 15  2016<br></body></html>
